And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...

The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers ...

US regulators, under the guidance of FDA Commissioner Marty Makary, are launching a program to accelerate drug approvals, ...

The program will bring together experts from across the FDA for a team-based review, rather than having an application move ...

According to an internal email, the agency may be in for more consolidation in areas including human resources, ...

Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...

Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England Journal of Medicine on May 20 requiring a stronger evidence base for boosters ...

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

The company vows to phase out artificial dyes by the end of 2027 — but points out most of their products are already dye-free ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...